Soft tissue augmentation applying a collagenated porcine dermal matrix during second stage surgery: A prospective multicenter case series

Kai R. Fischer, Tiziano Testori, Hannes Wachtel, Sven Mühlemann, Arndt Happe, Massimo Del Fabbro

Research output: Contribution to journalArticle

Abstract

Background: The achievement and preservation of an adequate amount of soft tissue around implants is a critical factor for the prognosis of the treatment. Purpose: To evaluate the effectiveness of a porcine dermal matrix applied during second stage implant surgery for horizontal soft tissue augmentation and preservation of dimensional stability. Materials and Methods: Twenty patients (mean age 50.2 ± 11.9 [SD] years) candidate to implant therapy and requiring soft tissue augmentation were recruited in four centers. Augmentation was performed in 24 cases. A porcine dermal matrix was placed into a buccal split-thickness pouch during uncovering surgery. Silicone impressions were taken before surgery (T0), 2 weeks later at suture removal (T2), 6 months (T3), and 24 months (T4) post augmentation. Dimensional changes of soft tissue were evaluated using superimposition of digitalized study casts. Results: Nineteen patients (23 implants) could be evaluated at 6 months and 13 patients (17 implants) at 24 months. After 6-month follow-up, there was a significant dimensional gain respect to baseline, averaging 0.83 ± 0.64 mm (P <.01). This did not change significantly at 24 months (0.77 ± 0.65 mm, P =.19). The gain was >0.5 mm in 65.2% and 64.7% of the cases, respectively. Soft tissue shrinkage averaged 34.2% ± 77.0% from T2 to T3 (P <.01) and did not change thereafter (P =.39). Shrinkage was more consistent in the posterior mandible than in the maxilla, but not significantly (P =.23 at 6-month and.36 at 24-month). No adverse events occurred. Conclusion: Within the limitations of this prospective case series, the use of a porcine dermal matrix may provide consistent soft tissue augmentation that maintains up to 24-month follow-up, although graft shrinkage may occur in the first 6 months, depending on the location of surgery.

Original languageEnglish
JournalClinical Implant Dentistry and Related Research
DOIs
Publication statusPublished - Jan 1 2019

Fingerprint

Swine
Skin
Soft Tissue Therapy
Tissue Preservation
Cheek
Maxilla
Silicones
Mandible
Sutures
Transplants
Therapeutics

Keywords

  • acellular dermal matrix
  • dental implant
  • gingival thickness
  • second stage surgery
  • soft tissue augmentation

ASJC Scopus subject areas

  • Oral Surgery
  • Dentistry(all)

Cite this

Soft tissue augmentation applying a collagenated porcine dermal matrix during second stage surgery : A prospective multicenter case series. / Fischer, Kai R.; Testori, Tiziano; Wachtel, Hannes; Mühlemann, Sven; Happe, Arndt; Del Fabbro, Massimo.

In: Clinical Implant Dentistry and Related Research, 01.01.2019.

Research output: Contribution to journalArticle

@article{4d3597d796794ab1b757d7433469c3f6,
title = "Soft tissue augmentation applying a collagenated porcine dermal matrix during second stage surgery: A prospective multicenter case series",
abstract = "Background: The achievement and preservation of an adequate amount of soft tissue around implants is a critical factor for the prognosis of the treatment. Purpose: To evaluate the effectiveness of a porcine dermal matrix applied during second stage implant surgery for horizontal soft tissue augmentation and preservation of dimensional stability. Materials and Methods: Twenty patients (mean age 50.2 ± 11.9 [SD] years) candidate to implant therapy and requiring soft tissue augmentation were recruited in four centers. Augmentation was performed in 24 cases. A porcine dermal matrix was placed into a buccal split-thickness pouch during uncovering surgery. Silicone impressions were taken before surgery (T0), 2 weeks later at suture removal (T2), 6 months (T3), and 24 months (T4) post augmentation. Dimensional changes of soft tissue were evaluated using superimposition of digitalized study casts. Results: Nineteen patients (23 implants) could be evaluated at 6 months and 13 patients (17 implants) at 24 months. After 6-month follow-up, there was a significant dimensional gain respect to baseline, averaging 0.83 ± 0.64 mm (P <.01). This did not change significantly at 24 months (0.77 ± 0.65 mm, P =.19). The gain was >0.5 mm in 65.2{\%} and 64.7{\%} of the cases, respectively. Soft tissue shrinkage averaged 34.2{\%} ± 77.0{\%} from T2 to T3 (P <.01) and did not change thereafter (P =.39). Shrinkage was more consistent in the posterior mandible than in the maxilla, but not significantly (P =.23 at 6-month and.36 at 24-month). No adverse events occurred. Conclusion: Within the limitations of this prospective case series, the use of a porcine dermal matrix may provide consistent soft tissue augmentation that maintains up to 24-month follow-up, although graft shrinkage may occur in the first 6 months, depending on the location of surgery.",
keywords = "acellular dermal matrix, dental implant, gingival thickness, second stage surgery, soft tissue augmentation",
author = "Fischer, {Kai R.} and Tiziano Testori and Hannes Wachtel and Sven M{\"u}hlemann and Arndt Happe and {Del Fabbro}, Massimo",
year = "2019",
month = "1",
day = "1",
doi = "10.1111/cid.12817",
language = "English",
journal = "Clinical Implant Dentistry and Related Research",
issn = "1523-0899",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Soft tissue augmentation applying a collagenated porcine dermal matrix during second stage surgery

T2 - A prospective multicenter case series

AU - Fischer, Kai R.

AU - Testori, Tiziano

AU - Wachtel, Hannes

AU - Mühlemann, Sven

AU - Happe, Arndt

AU - Del Fabbro, Massimo

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Background: The achievement and preservation of an adequate amount of soft tissue around implants is a critical factor for the prognosis of the treatment. Purpose: To evaluate the effectiveness of a porcine dermal matrix applied during second stage implant surgery for horizontal soft tissue augmentation and preservation of dimensional stability. Materials and Methods: Twenty patients (mean age 50.2 ± 11.9 [SD] years) candidate to implant therapy and requiring soft tissue augmentation were recruited in four centers. Augmentation was performed in 24 cases. A porcine dermal matrix was placed into a buccal split-thickness pouch during uncovering surgery. Silicone impressions were taken before surgery (T0), 2 weeks later at suture removal (T2), 6 months (T3), and 24 months (T4) post augmentation. Dimensional changes of soft tissue were evaluated using superimposition of digitalized study casts. Results: Nineteen patients (23 implants) could be evaluated at 6 months and 13 patients (17 implants) at 24 months. After 6-month follow-up, there was a significant dimensional gain respect to baseline, averaging 0.83 ± 0.64 mm (P <.01). This did not change significantly at 24 months (0.77 ± 0.65 mm, P =.19). The gain was >0.5 mm in 65.2% and 64.7% of the cases, respectively. Soft tissue shrinkage averaged 34.2% ± 77.0% from T2 to T3 (P <.01) and did not change thereafter (P =.39). Shrinkage was more consistent in the posterior mandible than in the maxilla, but not significantly (P =.23 at 6-month and.36 at 24-month). No adverse events occurred. Conclusion: Within the limitations of this prospective case series, the use of a porcine dermal matrix may provide consistent soft tissue augmentation that maintains up to 24-month follow-up, although graft shrinkage may occur in the first 6 months, depending on the location of surgery.

AB - Background: The achievement and preservation of an adequate amount of soft tissue around implants is a critical factor for the prognosis of the treatment. Purpose: To evaluate the effectiveness of a porcine dermal matrix applied during second stage implant surgery for horizontal soft tissue augmentation and preservation of dimensional stability. Materials and Methods: Twenty patients (mean age 50.2 ± 11.9 [SD] years) candidate to implant therapy and requiring soft tissue augmentation were recruited in four centers. Augmentation was performed in 24 cases. A porcine dermal matrix was placed into a buccal split-thickness pouch during uncovering surgery. Silicone impressions were taken before surgery (T0), 2 weeks later at suture removal (T2), 6 months (T3), and 24 months (T4) post augmentation. Dimensional changes of soft tissue were evaluated using superimposition of digitalized study casts. Results: Nineteen patients (23 implants) could be evaluated at 6 months and 13 patients (17 implants) at 24 months. After 6-month follow-up, there was a significant dimensional gain respect to baseline, averaging 0.83 ± 0.64 mm (P <.01). This did not change significantly at 24 months (0.77 ± 0.65 mm, P =.19). The gain was >0.5 mm in 65.2% and 64.7% of the cases, respectively. Soft tissue shrinkage averaged 34.2% ± 77.0% from T2 to T3 (P <.01) and did not change thereafter (P =.39). Shrinkage was more consistent in the posterior mandible than in the maxilla, but not significantly (P =.23 at 6-month and.36 at 24-month). No adverse events occurred. Conclusion: Within the limitations of this prospective case series, the use of a porcine dermal matrix may provide consistent soft tissue augmentation that maintains up to 24-month follow-up, although graft shrinkage may occur in the first 6 months, depending on the location of surgery.

KW - acellular dermal matrix

KW - dental implant

KW - gingival thickness

KW - second stage surgery

KW - soft tissue augmentation

UR - http://www.scopus.com/inward/record.url?scp=85069847627&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85069847627&partnerID=8YFLogxK

U2 - 10.1111/cid.12817

DO - 10.1111/cid.12817

M3 - Article

AN - SCOPUS:85069847627

JO - Clinical Implant Dentistry and Related Research

JF - Clinical Implant Dentistry and Related Research

SN - 1523-0899

ER -